HCP
GILD icon

Hexagon Capital Partners’s Gilead Sciences GILD Stock Holding History

Hexagon Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Buy
6,901
+154
+2% +$20.3K 0.12% 86
2026
Q1 		$940K Buy
+6,747
New +$945K 0.14% 69
2025
Q2 		– Sell
-8,852
Closed -$992K – 715
2025
Q1 		$992K Sell
8,852
-584
-6% -$60.3K 0.19% 56
2024
Q4 		$872K Sell
9,436
-97
-1% -$8.73K 0.16% 65
2024
Q3 		$799K Sell
9,533
-684
-7% -$52.2K 0.16% 65
2024
Q2 		$701K Buy
10,217
+1,506
+17% +$101K 0.15% 70
2024
Q1 		$638K Sell
8,711
-746
-8% -$57.4K 0.14% 75
2023
Q4 		$766K Sell
9,457
-175
-2% -$13.6K 0.18% 59
2023
Q3 		$722K Buy
9,632
+1,218
+14% +$93.7K 0.19% 51
2023
Q2 		$648K Sell
8,414
-403
-5% -$32.1K 0.17% 55
2023
Q1 		$732K Buy
8,817
+8
+0.1% +$663 0.2% 47
2022
Q4 		$756K Sell
8,809
-2,636
-23% -$209K 0.22% 45
2022
Q3 		$706K Buy
11,445
+6,119
+115% +$386K 0.21% 53
2022
Q2 		$329K Buy
5,326
+1,689
+46% +$105K 0.1% 123
2022
Q1 		$216K Buy
3,637
+1,518
+72% +$97K 0.06% 172
2021
Q4 		$154K Hold
2,119
– – 0.04% 212
2021
Q3 		$148K Hold
2,119
– – 0.04% 194
2021
Q2 		$146K Buy
2,119
+200
+10% +$13.4K 0.04% 194
2021
Q1 		$124K Buy
1,919
+500
+35% +$32.2K 0.03% 194
2020
Q4 		$82K Sell
1,419
-300
-17% -$18.1K 0.02% 215
2020
Q3 		$100K Buy
+1,719
New +$119K 0.03% 176

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hexagon Capital Partners's GILD Position: Q2 2026 in Review

Hexagon Capital Partners increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $20.3K and bringing the position to 6,901 shares worth $872K. The position accounts for 0.12% of the portfolio, ranked #86.

Hexagon Capital Partners first reported a position in GILD in Q3 2020 and has held it in 21 quarters since. The position peaked at $992K in Q1 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hexagon Capital Partners held 6,901 shares of Gilead Sciences worth $872K as of Q2 2026.
  • Hexagon Capital Partners bought 154 Gilead Sciences shares in Q2 2026, an estimated $20.3K.
  • Gilead Sciences made up 0.12% of Hexagon Capital Partners's portfolio in Q2 2026, its #86 holding.
  • Hexagon Capital Partners first reported a position in Gilead Sciences in Q3 2020 and has held it in 21 quarters since.
  • Hexagon Capital Partners's Gilead Sciences position peaked at $992K in Q1 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.